Did You Know?

Editor’s Picks

Latest News

University of Toledo Health Scales Nabla’s Ambient AI After Unlocking Better Documentation Precision and Revenue Cycle Performance

Health system reports faster chart closure, reduced documentation burden, and improved operational efficiency across multiple specialtiesNEW YORK, March 31, 2026...

n6 Appoints Broad Institute Principal Investigator Aziz Al’Khafaji as Scientific Advisor, Advancing AutoNorm™ as the New Standard in NGS Library Preparation

Pioneering genomics researcher and Methods Development Lab director joins n6 to accelerate adoption of AutoNorm across the research and clinical...

Infinx Named as a Representative Vendor in Gartner(R) 2026 Market Guide for Intelligent Prior Authorization, U.S. Healthcare Organizations

CUPERTINO, CA / ACCESS Newswire / March 31, 2026 / Infinx Healthcare, a technology-enabled revenue cycle solutions provider, announced today...

TRNR Reports Record Full-Year 2025 Results, Driven by 114% Revenue Growth; Confirms 2026 Guidance of $30M+ in Pro Forma Revenue & $0.5M Stock Repurchase Program

Full-Year Net Loss of $24.0 Million; Full Year Adjusted EBITDA Loss of Approximately $9.6 Million2025 Revenue would have been $20.7...

4basebio announces major expansion to support the growing demand of RUO and HQ synthetic DNA with lease of an innovation hub and manufacturing facility in Cambridge, UK

4basebio PLC ("4basebio" or the "Company") Cambridge, UK, 31 March 2026 – 4basebio PLC (AIM: 4BB), a specialist in synthetic...

Biomea Fusion Announces First Patient Dosed in Newly Initiated Phase II Programs Enrolling Type 2 Diabetes Patients Failing on Standard-of-Care Therapies

COVALENT-211 Phase II enrolling insulin-deficient type 2 diabetes patients COVALENT-212 Phase II enrolling type 2 diabetes patients uncontrolled with a GLP-1...

error: Content is protected !!